TP53 and diffuse large B-cell lymphoma: Conversely, p65 antagonized p53 function as suggested by survival analysis: in WT-TP53 DLBCL, patients with p65high expression correlated with significantly decreased PFS (P = 0.0076, Fig. 2C) and OS (P = 0.0082) rates than patients with p65low tumors, independent of GCB and ABC cell-of-origin.